Compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3 and A are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
式(I)的化合物或其药用盐,其中X、R1、R2、R3和A的定义如本文所述。还公开了制备这些化合物的方法,并将这些化合物用于治疗与LRRK2受体相关的疾病,如帕
金森病。